76
Participants
Start Date
October 26, 2017
Primary Completion Date
December 19, 2018
Study Completion Date
May 8, 2019
ReCell® Autologous Cell Harvesting Device
RES (Regenerative Epithelial Suspension) derived from the use of the ReCell® device will be applied over skin grafts meshed more widely than conventional autografting.
MedStar Washington Hospital Center, Washington D.C.
Wake Forest Baptist Medical Center, Winston-Salem
Tampa General Hospital, Tampa
University Medical Center, New Orleans
Arizona Burn Center at Maricopa Integrated Health Systems, Phoenix
University of Tennessee Health Science Center, Memphis
Lead Sponsor
Collaborators (1)
Advanced Clinical Research Services, LLC
OTHER
Avita Medical
INDUSTRY